SCHEMBL3370190

SCHEMBL3370190

CC1(C)COB(c2cc(-c3ccc4c(c3)OCO4)n(S(=O)(=O)c3cccc(Cl)c3)c2)OC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GLRA3 O75311 4/20 0.39
GLRB P48167 4/20 0.39
HTR6 P50406 10/20 0.35
ALDH1A1 P00352 3/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
KDM4E B2RXH2 1/20 0.35
GAA P10253 1/20 0.35
HPGD P15428 1/20 0.35
ALOX15 P16050 1/20 0.35
TSHR P16473 1/20 0.35
MAPK1 P28482 1/20 0.35
HSD17B10 Q99714 1/20 0.35
LMNA P02545 1/20 0.35
PKM P14618 1/20 0.35
HTT P42858 1/20 0.35
KDM1A O60341 1/20 0.35
MAOA P21397 1/20 0.35
CYP3A4 P08684 1/20 0.34
FYN P06241 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3368457 0.79 GLRA3 (0.42) GLRA3GLRBHTR6ALDH1A1MEN1
SCHEMBL3367906 0.77 GLRA3 (0.41) GLRA3GLRBHTR6ALDH1A1MEN1
SCHEMBL4455226 0.75 CHEK2 (0.40) GLRA3GLRBALDH1A1MEN1KMT2A
SCHEMBL3368757 0.69 HTR6 (0.44) HTR6ALDH1A1MEN1KMT2AKDM4E
SCHEMBL5899619 0.66 CYP3A4 (0.39) ALDH1A1MAPK1HSD17B10CYP3A4
SCHEMBL3368168 0.65 L3MBTL1 (0.38) ALDH1A1MEN1KMT2AKDM4EHSD17B10
SCHEMBL5892466 0.65 MEN1 (0.38) ALDH1A1MEN1KMT2AHPGDTSHR
SCHEMBL17520500 0.63 FYN (0.45) ALDH1A1MEN1KMT2AKDM4EHPGD
SCHEMBL17520499 0.62 HTT (0.46) ALDH1A1KDM4EGAAHPGDALOX15
SCHEMBL3370217 0.62 MAPT (0.45) ALDH1A1MEN1KMT2AKDM4ETSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1628957-B1 SULFOPYRROLES TAKEDA PHARMACEUTICAL (JP) 2010-09-29 EP disclosed
US-7612064-B2 Sulfopyrroles TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-11-03 US disclosed
US-20070060570-A1 Sulfopyrroles TALEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-03-15 US disclosed
EP-1628957-A1 SULFOPYRROLES Takeda Pharmaceutical Company Limited (JP) 2006-03-01 EP disclosed
WO-2004103968-A1 SULFOPYRROLES APONETICS AG (CH) 2004-12-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060570-A1 Sulfopyrroles TYK2, ARSA, SULT2A1 GLRA3 1851/4885GLRB 2523/4885HTR6 1949/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.